354 related articles for article (PubMed ID: 15604281)
21. Adenoviral expression of XIAP antisense RNA induces apoptosis in glioma cells and suppresses the growth of xenografts in nude mice.
Naumann U; Bähr O; Wolburg H; Altenberend S; Wick W; Liston P; Ashkenazi A; Weller M
Gene Ther; 2007 Jan; 14(2):147-61. PubMed ID: 16957768
[TBL] [Abstract][Full Text] [Related]
22. Crossroads of estrogen receptor and NF-kappaB signaling.
Biswas DK; Singh S; Shi Q; Pardee AB; Iglehart JD
Sci STKE; 2005 Jun; 2005(288):pe27. PubMed ID: 15956359
[TBL] [Abstract][Full Text] [Related]
23. Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation.
Tse AK; Wan CK; Shen XL; Yang M; Fong WF
Biochem Pharmacol; 2005 Nov; 70(10):1443-57. PubMed ID: 16181613
[TBL] [Abstract][Full Text] [Related]
24. Nuclear factor-kappaB inhibition by parthenolide potentiates the efficacy of Taxol in non-small cell lung cancer in vitro and in vivo.
Zhang D; Qiu L; Jin X; Guo Z; Guo C
Mol Cancer Res; 2009 Jul; 7(7):1139-49. PubMed ID: 19584264
[TBL] [Abstract][Full Text] [Related]
25. Aggravated endoplasmic reticulum stress as a basis for enhanced glioblastoma cell killing by bortezomib in combination with celecoxib or its non-coxib analogue, 2,5-dimethyl-celecoxib.
Kardosh A; Golden EB; Pyrko P; Uddin J; Hofman FM; Chen TC; Louie SG; Petasis NA; Schönthal AH
Cancer Res; 2008 Feb; 68(3):843-51. PubMed ID: 18245486
[TBL] [Abstract][Full Text] [Related]
26. Identification of the genes involved in enhanced fenretinide-induced apoptosis by parthenolide in human hepatoma cells.
Park JH; Liu L; Kim IH; Kim JH; You KR; Kim DG
Cancer Res; 2005 Apr; 65(7):2804-14. PubMed ID: 15805281
[TBL] [Abstract][Full Text] [Related]
27. NF-kappaB and estrogen receptor alpha interactions: Differential function in estrogen receptor-negative and -positive hormone-independent breast cancer cells.
Gionet N; Jansson D; Mader S; Pratt MA
J Cell Biochem; 2009 Jun; 107(3):448-59. PubMed ID: 19350539
[TBL] [Abstract][Full Text] [Related]
28. In vitro and in vivo activity of the nuclear factor-kappaB inhibitor sulfasalazine in human glioblastomas.
Robe PA; Bentires-Alj M; Bonif M; Rogister B; Deprez M; Haddada H; Khac MT; Jolois O; Erkmen K; Merville MP; Black PM; Bours V
Clin Cancer Res; 2004 Aug; 10(16):5595-603. PubMed ID: 15328202
[TBL] [Abstract][Full Text] [Related]
29. Aryl hydrocarbon receptor-mediated apoptosis of neuronal cells: a possible interaction with estrogen receptor signaling.
Kajta M; Wójtowicz AK; Maćkowiak M; Lasoń W
Neuroscience; 2009 Jan; 158(2):811-22. PubMed ID: 19027052
[TBL] [Abstract][Full Text] [Related]
30. Molecular mechanisms of selective estrogen receptor modulator (SERM) action.
Dutertre M; Smith CL
J Pharmacol Exp Ther; 2000 Nov; 295(2):431-7. PubMed ID: 11046073
[TBL] [Abstract][Full Text] [Related]
31. Tamoxifen-induced antitumorigenic/antiestrogenic action synergized by a selective aryl hydrocarbon receptor modulator.
McDougal A; Wormke M; Calvin J; Safe S
Cancer Res; 2001 May; 61(10):3902-7. PubMed ID: 11358803
[TBL] [Abstract][Full Text] [Related]
32. 1'S-1'-acetoxyeugenol acetate: a novel phenylpropanoid from Alpinia conchigera enhances the apoptotic effects of paclitaxel in MCF-7 cells through NF-κB inactivation.
In LL; Azmi MN; Ibrahim H; Awang K; Nagoor NH
Anticancer Drugs; 2011 Jun; 22(5):424-34. PubMed ID: 21346553
[TBL] [Abstract][Full Text] [Related]
33. Co-targeting the insulin-like growth factor I receptor enhances growth-inhibitory and pro-apoptotic effects of anti-estrogens in human breast cancer cell lines.
Chakraborty AK; Welsh A; Digiovanna MP
Breast Cancer Res Treat; 2010 Apr; 120(2):327-35. PubMed ID: 19337828
[TBL] [Abstract][Full Text] [Related]
34. Low-dose chemotherapy combined with an antiangiogenic drug reduces human glioma growth in vivo.
Bello L; Carrabba G; Giussani C; Lucini V; Cerutti F; Scaglione F; Landré J; Pluderi M; Tomei G; Villani R; Carroll RS; Black PM; Bikfalvi A
Cancer Res; 2001 Oct; 61(20):7501-6. PubMed ID: 11606386
[TBL] [Abstract][Full Text] [Related]
35. EphA2 overexpression decreases estrogen dependence and tamoxifen sensitivity.
Lu M; Miller KD; Gokmen-Polar Y; Jeng MH; Kinch MS
Cancer Res; 2003 Jun; 63(12):3425-9. PubMed ID: 12810680
[TBL] [Abstract][Full Text] [Related]
36. Gene expression changes induced by estrogen and selective estrogen receptor modulators in primary-cultured human endometrial cells: signals that distinguish the human carcinogen tamoxifen.
Pole JC; Gold LI; Orton T; Huby R; Carmichael PL
Toxicology; 2005 Jan; 206(1):91-109. PubMed ID: 15590111
[TBL] [Abstract][Full Text] [Related]
37. Identification of CD70-mediated apoptosis of immune effector cells as a novel immune escape pathway of human glioblastoma.
Wischhusen J; Jung G; Radovanovic I; Beier C; Steinbach JP; Rimner A; Huang H; Schulz JB; Ohgaki H; Aguzzi A; Rammensee HG; Weller M
Cancer Res; 2002 May; 62(9):2592-9. PubMed ID: 11980654
[TBL] [Abstract][Full Text] [Related]
38. Effects of SP500263, a novel, potent antiestrogen, on breast cancer cells and in xenograft models.
Brady H; Desai S; Gayo-Fung LM; Khammungkhune S; McKie JA; O'Leary E; Pascasio L; Sutherland MK; Anderson DW; Bhagwat SS; Stein B
Cancer Res; 2002 Mar; 62(5):1439-42. PubMed ID: 11888917
[TBL] [Abstract][Full Text] [Related]
39. Tamoxifen-mediated growth inhibition of human cholangiocarcinoma.
Sampson LK; Vickers SM; Ying W; Phillips JO
Cancer Res; 1997 May; 57(9):1743-9. PubMed ID: 9135018
[TBL] [Abstract][Full Text] [Related]
40. Parthenolide, an NF-κB inhibitor, suppresses tumor growth and enhances response to chemotherapy in gastric cancer.
Sohma I; Fujiwara Y; Sugita Y; Yoshioka A; Shirakawa M; Moon JH; Takiguchi S; Miyata H; Yamasaki M; Mori M; Doki Y
Cancer Genomics Proteomics; 2011; 8(1):39-47. PubMed ID: 21289336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
